Mandate

Litorina invests in Fractal Design

December 01, 2016

Vinge has advised Litorina IV in connection with its acquisition of Fractal Design, a leading Swedish actor within development and sale of chassis, fans, cooling systems and power to gaming computers.

The company has a turnover of approximately SEK 250 million and sells approximately 400 000 chassis per year. The company’s founder and CEO as well as other key persons will continue as significant owners of the company.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Filip Öhrner, Christian Brelin and Manne Bergström. Partner Louise Brorsson Salomon and associates Adam Sandberg and Josefine Lanker advised on financing issues.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024